AS ONE Corporation (TYO:7476)
2,470.00
+20.00 (0.82%)
Jan 9, 2026, 3:30 PM JST
AS ONE Revenue
AS ONE had revenue of 25.78B JPY in the quarter ending September 30, 2025, with 5.38% growth. This brings the company's revenue in the last twelve months to 106.54B, up 6.48% year-over-year. In the fiscal year ending March 31, 2025, AS ONE had annual revenue of 103.75B with 8.60% growth.
Revenue (ttm)
106.54B
Revenue Growth
+6.48%
P/S Ratio
1.64
Revenue / Employee
145.74M
Employees
731
Market Cap
174.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 103.75B | 8.22B | 8.60% |
| Mar 31, 2024 | 95.54B | 4.12B | 4.50% |
| Mar 31, 2023 | 91.42B | 4.47B | 5.14% |
| Mar 31, 2022 | 86.95B | 5.35B | 6.55% |
| Mar 31, 2021 | 81.61B | 11.22B | 15.94% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |
AS ONE News
- 7 months ago - Hong Kong pro-democracy business hit with ‘unwarranted’ tax demand, owner says - Hong Kong Free Press